[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$ff_sI4i13wuTaWTgEn6dMFh5y6BNzvAKrzBn4aZFVkZo":8,"$f37O8ICSx8RXBBAo5jZFl-oKR0BmkGjTDYHz3KFOcg2g":55,"$f2gU1GJFSEDplWfXVlyZWMzen0NqoFFrfU1We2HI2XyA":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},59033,867211,[],"https://ystcdn.venuertc.com/medical/ystApp/FRfzTr7rRcZ9NIepJ9KtSQ9JF0EHCJzK.png","赵念初","新乐市中医医院","肿瘤科","住院医师",186,0,"肝癌二期用药必读：介入化疗栓塞和射频消融的详细用药指南","","https://ystcdn.venuertc.com/venue/AI/5b976bbd-8795-4e1e-9688-f44af9ca96e8.jpg","\u003Cdiv class=\"liver-cancer-material-container\">\n  \u003Ch1 id=\"material_title\" class=\"liver-cancer-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    肝癌二期用药必读：介入化疗栓塞和射频消融的详细用药指南\n  \u003C/h1>\n\n  \u003Cdiv class=\"liver-cancer-section\" style=\"background: linear-gradient(90deg, #f7fafc 60%, #e9f5ee 100%);\">\n    \u003Ch2 class=\"liver-cancer-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">1. 介入化疗栓塞与射频消融：常见药品简介\u003C/h2>\n    \u003Cdiv class=\"liver-cancer-section-content\">\n      说起肝癌二期的治疗，不少人会接触到“介入化疗栓塞术（TACE）”和“射频消融（RFA）”这样的介入手段，其实，这两项技术都离不开药品的安全规范使用。\u003Cbr>\n      \u003Cspan class=\"liver-cancer-highlight\">介入化疗栓塞\u003C/span>常用药物包含化疗药（如多柔比星、顺铂等）、栓塞剂（如碘化油、明胶颗粒等）；\u003Cspan class=\"liver-cancer-highlight\">射频消融\u003C/span>则主要借助消融电极配合镇痛镇静、抗生素等辅助用药。\u003Cbr>\n      今天，我们将一一说清这些药品的作用原理、正确用法，以及每一步容易忽略的用药细节，让你熟练掌握安全用药的全流程。下文包含7个重点部分，信息量很大，建议收藏！\n    \u003C/div>\n  \u003C/div>\n\n\n  \u003Cdiv class=\"liver-cancer-section\" style=\"background: linear-gradient(90deg, #e9f5ee 60%, #f7fafc 100%);\">\n    \u003Ch2 class=\"liver-cancer-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">2. 化疗药及栓塞剂：基本成分与剂型区别\u003C/h2>\n    \u003Cdiv class=\"liver-cancer-section-content\">\n      在TACE介入过程中，最常用的药品类型有两类：\u003Cbr>\n      \u003Cul class=\"liver-cancer-ul\">\n        \u003Cli>\n          \u003Cstrong>化疗药\u003C/strong>：如\u003Cspan class=\"liver-cancer-highlight\">多柔比星\u003C/span>（Doxorubicin）、\u003Cspan class=\"liver-cancer-highlight\">顺铂\u003C/span>（Cisplatin）、\u003Cspan class=\"liver-cancer-highlight\">氟尿嘧啶\u003C/span>（5-FU）等，绝大多数为注射剂型，通过导管直接输入指定血管。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>栓塞材料\u003C/strong>：有\u003Cspan class=\"liver-cancer-highlight\">碘化油\u003C/span>注射液、明胶海绵微粒，以及新式微球等，负责编织阻断肿瘤供血。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"liver-cancer-tip\">正确做法：\u003C/span>所有药品均由医护专业人员配制、维持无菌环境，不自行操作。普通患者只需了解药品名称和剂型，便于自我识别和配合告知过敏史。\u003Cbr>\n      \u003Cspan class=\"liver-cancer-danger\">请勿自行拆开、稀释、注射或混合这些药物！\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n\n  \u003Cdiv class=\"liver-cancer-section\" style=\"background: linear-gradient(90deg, #f7fafc 60%, #e9f5ee 100%);\">\n    \u003Ch2 class=\"liver-cancer-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">3. 作用机制知多少？核心药品怎样发挥效力\u003C/h2>\n    \u003Cdiv class=\"liver-cancer-section-content\">\n      药品的工作方式其实很简单：\u003Cbr>\n      \u003Cul class=\"liver-cancer-ul\">\n        \u003Cli>\n          \u003Cspan class=\"liver-cancer-highlight\">化疗药\u003C/span>通过破坏肿瘤内的DNA合成，使细胞分裂受阻。像多柔比星这样的大分子药，通过阻断癌细胞复制，杀伤肿瘤组织。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"liver-cancer-highlight\">栓塞剂\u003C/span>的作用主要是“堵”，把营养通路卡断，让肿瘤逐步坏死缩小。许多临床数据都证实，TACE这种“断粮”模式可以提升治疗效果 \u003Cspan class=\"liver-cancer-cite\">(Bruix & Sherman, 2011)\u003C/span>。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"liver-cancer-highlight\">射频消融\u003C/span>主要靠消融针释放能量，让病变组织迅速高温凝固坏死。在此过程中，镇痛药和镇静药保障患者耐受过程，防止身体过度应激和疼痛。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"liver-cancer-tip\">这些药品机制均有强针对性，因此简单误用或超剂量都会有典型风险。\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n\n  \u003Cdiv class=\"liver-cancer-section\" style=\"background: linear-gradient(90deg, #e9f5ee 60%, #f7fafc 100%);\">\n    \u003Ch2 class=\"liver-cancer-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">4. 正确用药方法和常见操作流程\u003C/h2>\n    \u003Cdiv class=\"liver-cancer-section-content\">\n      \u003Cspan class=\"liver-cancer-emoji\">🩺\u003C/span> \u003Cspan class=\"liver-cancer-bold\">介入化疗栓塞\u003C/span>：\n      \u003Col class=\"liver-cancer-ol\">\n        \u003Cli>由医生在无菌操作下穿刺血管，导管定位到目标动脉。\u003C/li>\n        \u003Cli>化疗药、栓塞剂按规定配比配制后，分步推进注射。\u003C/li>\n        \u003Cli>全过程医生精确控制剂量，依据体重、肝功能等评估调整药量。\u003C/li>\n        \u003Cli>术后需卧床观察至少6小时，预防出血和感染。\u003C/li>\n      \u003C/ol>\n      \u003Cspan class=\"liver-cancer-emoji\">⚡\u003C/span> \u003Cspan class=\"liver-cancer-bold\">射频消融\u003C/span>操作中：\n      \u003Col class=\"liver-cancer-ol\">\n        \u003Cli>重要用药包括：麻醉药（如依托咪酯）、镇痛药（如芬太尼）、适当的抗生素预防术后感染。\u003C/li>\n        \u003Cli>药品给药时间主要在术中或术后早期，可根据患者反应适当延长。\u003C/li>\n        \u003Cli>辅助药物需逐项查对无过敏史，尤其要关注麻醉及抗生素过敏。\u003C/li>\n      \u003C/ol>\n      \u003Cdiv>\n        \u003Cspan class=\"liver-cancer-tip\">临床案例：\u003C/span>\n        有位72岁男性患者曾因肝癌二期反复行TACE联合射频消融，每次均严格遵循药品配比与操作顺序，未发生严重不良反应。但其对头孢类抗生素过敏，术前多次强调请勿用此类药品，有效规避了过敏风险。\n      \u003C/div>\n      \u003Cdiv>\n        \u003Cspan class=\"liver-cancer-danger\">特别提醒：\u003C/span>\n        禁止私自要求增加药量或更换注射药品，在手术过程中如有药品更改需求，务必充分知情同意。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n  \n\n  \u003Cdiv class=\"liver-cancer-section\" style=\"background: linear-gradient(90deg, #f7fafc 60%, #e9f5ee 100%);\">\n    \u003Ch2 class=\"liver-cancer-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">5. 药品的相互作用与特殊注意事项\u003C/h2>\n    \u003Cdiv class=\"liver-cancer-section-content\">\n      介入化疗栓塞常用药物与其他药物之间可能存在相互作用，包括：\n      \u003Cul class=\"liver-cancer-ul\">\n        \u003Cli>\n          \u003Cstrong>多柔比星与抗氧化类药物\u003C/strong>：如同时服用维生素C、E等抗氧化剂，可能影响化疗药性能，降低药效。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>顺铂、5-FU等联合用药\u003C/strong>：合用时需调整剂量，谨防骨髓抑制与肝肾毒性风险升高。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>抗生素与肝用药\u003C/strong>：如有青霉素、头孢类过敏史，必须主动报告，防止严重过敏反应。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>射频消融辅助药物\u003C/strong>：麻醉及镇痛用药若与镇静催眠类药物同用，可能诱发呼吸抑制，需严格动态监护。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"liver-cancer-tip\">\n        正确做法：术前将所有慢性用药如降压药、糖尿病药等完整告知医生，避免遗漏可能导致意外。\n      \u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n\n  \u003Cdiv class=\"liver-cancer-section\" style=\"background: linear-gradient(90deg, #e9f5ee 60%, #f7fafc 100%);\">\n    \u003Ch2 class=\"liver-cancer-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">6. 不良反应与处理要点\u003C/h2>\n    \u003Cdiv class=\"liver-cancer-section-content\">\n      很多患者和家属最关心的就是治疗过程中的药物副作用。\u003Cbr>\n      \u003Cspan class=\"liver-cancer-emoji\">⛳\u003C/span> 常见不良反应分为以下几类：\n      \u003Cul class=\"liver-cancer-ul\">\n        \u003Cli>\n          \u003Cb>化疗药\u003C/b>（如多柔比星、顺铂）：注射部位炎症、恶心呕吐、脱发、骨髓抑制等。数据显示，这类不良反应发生率在30%上下，但大多数可控 \u003Cspan class=\"liver-cancer-cite\">(Llovet et al., 2002)\u003C/span>。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>栓塞剂\u003C/b>：术后可能出现发热、局部疼痛、乏力等“栓塞反应”，通常数天自动缓解。如持续不退高热或剧痛，应及时复查。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>射频消融中辅助药\u003C/b>：麻醉药过量可能引发过敏、呼吸抑制。抗生素不良反应多为皮疹、肝功异常，个别病例可能严重。曾有患者因未提前报告抗生素过敏史，术后出现皮肤红斑，经对症处理后好转，此类风险需引起高度重视。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"liver-cancer-tip\">\n        出现严重不良反应的处理方法：立即通知医护，不要自行停药或增加其他药品。化疗期出现感染征象、持续呕吐、严重乏力等须及时回院随访。\n      \u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n\n  \u003Cdiv class=\"liver-cancer-section\" style=\"background: linear-gradient(90deg, #f7fafc 60%, #e9f5ee 100%);\">\n    \u003Ch2 class=\"liver-cancer-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">7. 储存管理与药品有效期\u003C/h2>\n    \u003Cdiv class=\"liver-cancer-section-content\">\n      介入用药物品多为注射剂，存放要求极为严格：\u003Cbr>\n      \u003Cul class=\"liver-cancer-ul\">\n        \u003Cli>\n          \u003Cspan class=\"liver-cancer-bold\">化疗药与栓塞剂\u003C/span>须在低温环境密闭保存，具体温度通常为2-8℃，不可冷冻。超温、反复开启将影响药效。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"liver-cancer-bold\">辅助药品（抗生素等）\u003C/span>遵循药盒外包装指引，大多要求避光、阴凉或按规定冷藏。注射液开封即用，不能久置。\n        \u003C/li>\n        \u003Cli>\n          所有药品切勿混用储存或随意丢弃！过期、变色或浑浊药品，一律按危险废弃药品处理，不可继续使用。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"liver-cancer-tip\">\n        患者不需自行保管介入用药，仅需了解存放要求。如家中需储存术后口服药，务必单独存放，远离儿童取得范围。\n      \u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n\n  \u003Cdiv class=\"liver-cancer-section\" style=\"background: linear-gradient(90deg, #e9f5ee 60%, #f7fafc 100%);\">\n    \u003Ch2 class=\"liver-cancer-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">8. 用药后健康管理与生活指导\u003C/h2>\n    \u003Cdiv class=\"liver-cancer-section-content\">\n      完成介入治疗或射频消融后，药品管理只是健康的一部分。术后辅助药品多以维持肝脏、胃肠及电解质平衡为主，也可能包含止吐、抑酸、补液等短期药物：\n      \u003Cul class=\"liver-cancer-ul\">\n        \u003Cli>\n          \u003Cb>用药顺序\u003C/b>要严格遵照医嘱，切忌自己加减药品，即使是常见的止痛片和维生素；\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>院外药品管理\u003C/b>：口服药需标明每日服用次数及时间表，不能因为“状态好”自行停药；\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>用药过程中如出现异常反应\u003C/b>，马上与随访医生联系及复查，忌“扛一扛就过去了”的心态；\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>家中储药\u003C/b>要远离儿童和宠物，定期清点药品日期、外观和包装，有异常即弃；\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>记录药品名称、服药习惯与过敏史\u003C/b>，必要时主动告诉医生和新护士，防止漏报。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"liver-cancer-tip\">健康管理离不开科学用药，药品管理做细了才能保证治疗全程安全顺畅。\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n\n  \u003Cdiv class=\"liver-cancer-section\" style=\"background: linear-gradient(90deg, #f7fafc 60%, #e9f5ee 100%);\">\n    \u003Ch2 class=\"liver-cancer-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">9. 药品使用误区小结与全程安全提醒\u003C/h2>\n    \u003Cdiv class=\"liver-cancer-section-content\">\n      \u003Cspan class=\"liver-cancer-emoji\">❗\u003C/span> \u003Cb>常见用药误区：\u003C/b>\n      \u003Cul class=\"liver-cancer-ul\">\n        \u003Cli>自作主张增加或更换介入药品；\u003C/li>\n        \u003Cli>未报出所有过敏史，遗漏重要信息；\u003C/li>\n        \u003Cli>以为“打点滴”都是普通药，未主动查对药品成分、用法；\u003C/li>\n        \u003Cli>用药说明书未认真阅读，产生操作差错。\u003C/li>\n      \u003C/ul>\n      \u003Cb class=\"liver-cancer-highlight\">关键点再强调——\u003C/b>\n      \u003Col class=\"liver-cancer-ol\">\n        \u003Cli>所有药品用法调整、组合、增减、调换，必须经专业医护评估同意\u003C/li>\n        \u003Cli>如有新不适或异常，一定要及时复查或原地联系随诊医生\u003C/li>\n        \u003Cli>药品储存、区分与废弃要规范，切勿混用与遗弃\u003C/li>\n      \u003C/ol>\n      \u003Cspan class=\"liver-cancer-tip\">\n        用药安全是全过程管理，做到以上几点，你在介入化疗栓塞或射频消融用药上的安全性就已经稳步提升！如果对药品内容还有具体疑问，记得向医生或药师详细咨询。\n      \u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n\n  \u003Cdiv class=\"liver-cancer-section\" style=\"background: linear-gradient(90deg, #e9f5ee 60%, #f7fafc 100%);\">\n    \u003Ch2 class=\"liver-cancer-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10. 文献引用\u003C/h2>\n    \u003Cdiv class=\"liver-cancer-section-content\">\n      \u003Col class=\"liver-cancer-ref-list\">\n        \u003Cli>\n          Bruix, J., & Sherman, M. (2011). Management of hepatocellular carcinoma: An update. \u003Ci>Hepatology\u003C/i>, 53(3), 1020-1022. https://doi.org/10.1002/hep.24199\n        \u003C/li>\n        \u003Cli>\n          Llovet, J. M., Real, M. I., Montaña, X., et al. (2002). Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. \u003Ci>Lancet\u003C/i>, 359(9319), 1734-1739. https://doi.org/10.1016/S0140-6736(02)08649-X\n        \u003C/li>\n      \u003C/ol>\n    \u003C/div>\n  \u003C/div>\n\n\u003C/div>\n\n\u003Cstyle>\n.liver-cancer-material-container {\n  max-width: 860px;\n  margin: 0 auto;\n  background: #fcfcfd;\n  padding: 32px 18px 40px 18px;\n  border-radius: 16px;\n  box-shadow: 0px 4px 36px 0px rgba(125, 173, 160, 0.12);\n  font-family: \"Segoe UI\", \"PingFang SC\", \"Hiragino Sans GB\", \"Arial\", sans-serif;\n  color: #223030;\n  line-height: 1.78;\n  letter-spacing: 0.5px;\n  font-size: 19px;\n}\n\n.liver-cancer-title {\n  font-size: 29px;\n  color: #238e81;\n  font-weight: bold;\n  padding-top: 5px;\n  padding-bottom: 22px;\n  text-align: left;\n  letter-spacing: 1.5px;\n  background: linear-gradient(90deg, #e9f5ee 90%, #f7fafc 100%);\n  border-radius: 8px 8px 0px 0px;\n  margin-bottom: 18px;\n}\n\n.liver-cancer-section {\n  margin-bottom: 40px;\n  padding: 26px 24px 22px 24px;\n  border-radius: 16px;\n  background: #f7fafc;\n  box-shadow: 0px 2px 16px 0px rgba(145,180,170,0.06);\n}\n\n.liver-cancer-section-title {\n  font-size: 22px;\n  font-weight: 600;\n  color: #087267;\n  letter-spacing: 1px;\n  margin-bottom: 16px;\n}\n\n.liver-cancer-section-content {\n  font-size: 18px;\n  color: #223030;\n  padding-bottom: 2px;\n}\n\n.liver-cancer-ul {\n  list-style: disc inside;\n  padding-left: 1.2em;\n  margin: 8px 0 18px 0;\n  font-size: 18px;\n}\n\n.liver-cancer-ol {\n  list-style: decimal inside;\n  padding-left: 1.5em;\n  margin: 8px 0 18px 0;\n  font-size: 18px;\n}\n\n.liver-cancer-highlight {\n  color: #139b76;\n  font-weight: bold;\n}\n\n.liver-cancer-tip {\n  color: #028c7b;\n  font-weight: 500;\n  display: inline-block;\n  margin-top: 7px;\n}\n\n.liver-cancer-danger {\n  color: #f33e31;\n  font-weight: 600;\n  display: inline-block;\n}\n\n.liver-cancer-bold {\n  font-weight: 600;\n  color: #16615b;\n}\n\n.liver-cancer-emoji {\n  font-size: 22px;\n  margin-right: 3px;\n  vertical-align: middle;\n}\n\n.liver-cancer-cite {\n  color: #888;\n  font-size: 16px;\n  font-style: italic;\n  font-weight: 400;\n  margin-left: 5px;\n}\n\n.liver-cancer-ref-list {\n  font-size: 16px;\n  padding-left: 1.4em;\n  color: #444;\n}\n\n@media (max-width: 500px) {\n  .liver-cancer-material-container {\n    padding: 10px 2px 20px 2px;\n    font-size: 16px;\n  }\n  .liver-cancer-title {\n    font-size: 21px;\n    padding-bottom: 14px;\n    margin-bottom: 10px;\n  }\n  .liver-cancer-section {\n    padding: 13px 7px 12px 7px;\n    margin-bottom: 17px;\n  }\n  .liver-cancer-section-title {\n    font-size: 16px;\n    margin-bottom: 8px;\n  }\n  .liver-cancer-section-content {\n    font-size: 15px;\n  }\n  .liver-cancer-ul, .liver-cancer-ol {\n    font-size: 15px;\n  }\n}\n\n\u003C/style>\n\n","\u003Cdiv class=\"liver-cancer-material-container\">\n  \u003Ch1 id=\"material_title\" class=\"liver-cancer-title\" s",504,"2025-08-14 15:15:43","肝癌治疗, 介入化疗栓塞, 射频消融, 用药指南, 化疗药物, 药物不良反应, 肝癌二期, 安全用药, 医学科普","了解肝癌二期患者必须知道的介入化疗栓塞（TACE）与射频消融（RFA）用药信息，确保用药安全与有效。本文提供详尽的药品介绍、使用注意事项及不良反应处理，助你科学应对肝癌。","2025-08-18 19:00:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]